Donna Lavoie

Ceo/ President

Donna is a proven strategic communications leader in health and science innovation. She is a trusted advisor on strategic communications issues, especially around complex issues where multiple stakeholders are affected. She brings a unique combination of public and investor relations expertise, including product launch experience.
LaVoieHealthScience was launched in 2001, after a corporate career with signature biotech companies leading strategic communications functions during tremendous growth, product and business launches and international geographic expansion.

For almost 20 years, Donna’s efforts combine building LaVoieHealthScience’s health and science consulting practice, while overseeing key account strategies, agency strategic direction, core competency and methodology development, growth strategies, and team development. In 2019, Donna led the efforts with Omnicom Public Relations Group (DAS Group of Companies) to form a strategic alliance to bring health companies a broader set of capabilities and geographic expansion.

As an acknowledged leader in health science communications with both public and investor platforms, LaVoieHealthScience is recognized as a top 30 independent healthcare agencies in the US. The agency has received more than 35 awards for its client work and is recognized by INC.5000 Hall of Fame – Fastest Growing Private Companies, Boston Business Journal’s top Massachusetts PR firms, PharmaVOICE 100 and by O’Dwyers.